Prevalence of feline immunodeficiency virus infection in domesticated and feral cats in eastern Australia

• Published in: Journal of feline medicine and surgery Vol. 9; no. 4; pp. 300 - 308
• Main Authors: Norris, Jacqueline M., Bell, Erin T., Hales, Louise, Toribio, Jenny-Ann L.M.L., White, Joanna D., Wigney, Denise I., Baral, Randolph M., Malik, Richard
• Format: Journal Article
• Language: English
• Published: London, England Elsevier Ltd 01.08.2007; SAGE Publications
• Subjects: analysis; Animals; Animals, Domestic; Animals, Wild; Antibodies, Viral; Antibodies, Viral - analysis; Australia; Australia - epidemiology; blood; Cats; disease prevalence; Enzyme-Linked Immunosorbent Assay; Enzyme-Linked Immunosorbent Assay - veterinary; epidemiology; etiology; Feline Acquired Immunodeficiency Syndrome; Feline Acquired Immunodeficiency Syndrome - blood; Feline Acquired Immunodeficiency Syndrome - epidemiology; Feline Acquired Immunodeficiency Syndrome - etiology; Feline immunodeficiency virus; Female; Immunodeficiency Virus, Feline; Immunodeficiency Virus, Feline - immunology; Immunodeficiency Virus, Feline - isolation & purification; immunology; isolation & purification; Male; Prevalence; veterinary; Australia
• DOI: 10.1016/j.jfms.2007.01.007
• ISSN: 1098-612X

Serum samples from 340 pet cats presented to three inner city clinics in Sydney Australia, 68 feral cats from two separate colonies in Sydney, and 329 cattery-confined pedigree and domestic cats in eastern Australia, were collected over a 2-year period and tested for antibodies directed against feline immunodeficiency virus (FIV) using immunomigration (Agen FIV Rapid Immunomigration test) and enzyme-linked immunosorbent assay methods (Snap Combo feline leukaemia virus antigen/FIV antibody test kit, IDEXX Laboratories). Western blot analysis was performed on samples in which there was discrepancy between the results. Information regarding breed, age, gender, housing arrangement and health status were recorded for all pet and cattery-confined cats, while the estimated age and current physical condition were recorded for feral cats. The FIV prevalence in the two feral cat populations was 21% and 25%. The majority of FIV-positive cats were male (60–80%). The FIV prevalence in cattery-confined cats was nil. The prevalence of FIV in the pet cat sample population was 8% (27/340) with almost equal prevalence in ‘healthy’ (13/170) and ‘systemically unwell’ (14/170) cats. The age of FIV-positive pet cats ranged from 3 to 19 years; all FIV-positive cats were domestic shorthairs with outside access. The median age of FIV-positive pet cats (11 years) was significantly greater than the median age of FIV-negative pet cats (7.5 years: P < 0.05). The prevalence of FIV infection in male pet cats (21/172; 12%) was three times that in female pet cats (6/168; 4%; P < 0.05). With over 80% of this pet cat population given outside access and continued FIV infection present in the feral population, this study highlights the need to develop rapid, accurate and cost-effective diagnostic methods that are not subject to false positives created by concurrent vaccination against FIV. This is especially important in re-homing stray cats within animal shelters and monitoring the efficacy of the new vaccine, which has not been challenged against Australian strains. The absence of FIV within cattery-confined cats highlights the value in routine screening and indoor lifestyles. This study provides cogent baseline FIV prevalences in three cat subpopulations which can be used for appraising potential disease associations with FIV in Australia.